Abstract:Phenotypic modulation of vascular smooth muscle cells (VSMCs) plays a critical role in the pathogenesis of a variety of proliferative vascular diseases. The cellular repressor of E1A-stimulated genes (CREG) has been shown to play an important role in phenotypic modulation of VSMCs. However, the mechanism regulating CREG upstream signaling remains unclear. MicroRNAs (miRNAs) have recently been found to play a critical role in cell differentiation via target-gene regulation. This study aimed to identify a miRNA that binds directly to CREG, and may thus be involved in CREG-mediated VSMC phenotypic modulation. Computational analysis indicated that miR-31 bound to the CREG mRNA 3′ untranslated region (3′-UTR). miR-31 was upregulated in quiescent differentiated VSMCs and downregulated in proliferative cells stimulated by platelet-derived growth factor and serum starvation, demonstrating a negative relationship with the VSMC differentiation marker genes, smooth muscle α-actin, calponin and CREG. Using gain-of-function and loss-of-function approaches, CREG and VSMC differentiation marker gene expression levels were shown to be suppressed by a miR-31 mimic, but increased by a miR-31 inhibitor at both protein and mRNA levels. Notably, miR-31 overexpression or inhibition affected luciferase expression driven by the CREG 3′-UTR containing the miR-31 binding site. Furthermore, miR-31-mediated VSMC phenotypic modulation was inhibited in CREG-knockdown human VSMCs. We also determined miR-31 levels in the serum of patients with coronary artery disease (CAD), with or without in stent restenosis and in healthy controls. miR-31 levels were higher in the serum of CAD patients with restenosis compared to CAD patients without restenosis and in healthy controls. In summary, these data demonstrate that miR-31 not only directly binds to its target gene CREG and modulates the VSMC phenotype through this interaction, but also can be an important biomarker in diseases involving VSMC phenotypic modulation. These novel findings may have extensive implications for the diagnosis and therapy of a variety of proliferative vascular diseases.

MicroRNA-29a Promotes Smooth Muscle Cell Differentiation from Stem Cells by Targeting YY1

All-Trans Retinoic Acid Promotes Smooth Muscle Cell Differentiation of Rabbit Bone Marrow-Derived Mesenchymal Stem Cells

MicroRNA-146a Promotes Embryonic Stem Cell Differentiation towards Vascular Smooth Muscle Cells through Regulation of Kruppel-like Factor 4

Microrna-34a Regulated Sirtuin 1 Is Required For Smooth Muscle Cell Differentiation From Murine And Human Embryonic Stem Cells

MicroRNA-214 regulates smooth muscle cell differentiation from stem cells by targeting RNA-binding protein QKI.

Abstract 14420: MicroRNA-214 Regulates Stem Cell Differentiation Into Smooth Muscle Cells by Targeting Quaking

The miR-29b/Matrix Metalloproteinase 2 Axis Regulates Transdifferentiation and Calcification of Vascular Smooth Muscle Cells in a Calcified Environment

MicroRNA-31 Controls Phenotypic Modulation of Human Vascular Smooth Muscle Cells by Regulating Its Target Gene Cellular Repressor of E1A-stimulated Genes

MicroRNA-129-5p Inhibits Vascular Smooth Muscle Cell Proliferation by Targeting Wnt5a.

MiR‐218 Regulated Cardiomyocyte Differentiation and Migration in Mouse Embryonic Stem Cells by Targeting PDGFRα

e0205 MicroRNA regulation of cardiomyocyte lineages from bone marrowderived mesenchymal stem cells

MicroRNA-145, a Novel Smooth Muscle Cell Phenotypic Marker and Modulator, Controls Vascular Neointimal Lesion Formation

YY1 directly interacts with myocardin to repress the triad myocardin/SRF/CArG box-mediated smooth muscle gene transcription during smooth muscle phenotypic modulation

Mir‐29 Contributes to Normal Endothelial Function and Can Restore It in Cardiometabolic Disorders

Aberrant expression of miR-29b-3p influences heart development and cardiomyocyte proliferation by targeting NOTCH2

Upregulated Sirtuin 1 by Mirna-34A is Required for Smooth Muscle Cell Differentiation from Pluripotent Stem Cells

Mechanisms of miR-29a-5p involvement in osteogenic phenotype transformation and cellular regulation of vascular smooth muscle and thus influencing calcification in VSMCs in chronic kidney disease

miRNA-34c inhibits myoblasts proliferation by targeting YY1

Flow-Regulation Of Vascular Smooth Muscle Cell Proliferation: Roles Of Endothelial Cell-Secreted Microrna-126

MiR-140-3p Normalizes Vascular Smooth Muscle Cell Behavior by Inhibiting the RhoA/ROCK Signaling Pathway in Lower-extremity Arteriosclerosis Obliterans

BMSCs-Derived Extracellular VesiclemiR-29a-3p Improved the Stability of Rat Myasthenia Gravis by Regulating Treg/Th17 Cells